Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-23-050869

President, R&D sold 648 shares at $8.38 ($5,430)

  • President, R&D acquired 1,228 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bergstrom Donald A President, R&D 2023-06-30 Grant or award +1,228 $10.68 $13,115 241,815 D
Bergstrom Donald A President, R&D 2023-09-27 Sale −648 $8.38 $5,430 238,484 D
Open-market sales · 648 sh · avg $8.38 · $5,430
Loading xslF345X05/doc4.xml…